Showing results (1761-1770 of 1,945) with videos related to
Sort By:
Pageof 195
Nature Communications|November 10, 2022
Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancersJennifer Cantley, Xiaofen Ye, Emma Rousseau, et al.Breast Cancer Research : BCR|March 22, 2012
Reproductive aging-associated common genetic variants and the risk of breast cancerChunyan He, Daniel I Chasman, Jill Dreyfus, et al.Science Translational Medicine|July 26, 2019
Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domainJames R Burke, Lihong Cheng, Kathleen M Gillooly, et al.Nature Communications|August 26, 2016
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinomaPatrizia Cammareri, Aidan M Rose, David F Vincent, et al.Lancet (London, England)|September 8, 2018
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy studyWilliam C Miller, Irving F Hoffman, Brett S Hanscom, et al.JCI Insight|January 12, 2018
Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosisYvonne Baumer, Qimin Ng, Gregory E Sanda, et al.Open Forum Infectious Diseases|August 30, 2021
Engaging People Who Inject Drugs Living With HIV in Antiretroviral Treatment and Medication for Opioid Use Disorder: Extended Follow-up of HIV Prevention Trials Network (HPTN) 074Kathryn E Lancaster, Katie R Mollan, Brett S Hanscom, et al.Journal of Oncology Practice|August 15, 2013
Practice-based evidence to evidence-based practice: building the National Radiation Oncology RegistryJason A Efstathiou, Deborah S Nassif, Todd R McNutt, et al.Nature Biotechnology|October 19, 2023
Systematic discovery of neoepitope-HLA pairs for neoantigens shared among patients and tumor typesHem R Gurung, Amy J Heidersbach, Martine Darwish, et al.The New England Journal of Medicine|November 19, 2010
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutationFrank J Accurso, Steven M Rowe, J P Clancy, et al.Pageof 195